NCT02207712 - Noctura400 Treatment for Diabetic Retinopathy (CANDLE) | Biotech Hunter

Enrollment

252

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions

Diabetic Macular Oedema

Interventions

DEVICE

Noctura 400 Eye Mask

The intervention is the wearing of the eye mask

DRUG

Ranibizumab

Standard ranibizumab treatment only

Trial Locations (18)

RG1 5AN

Royal Berkshire NHS Foundation Trust, Reading

PE29 6NT

Hitchingbrooke Healthcare NHS Trust, Huntingdon

PE3 9GZ

Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough

TS4 3BW

South Tees Hospitals NHS Foundation Trust, Middlesbrough

TR1 3LJ

Royal Cornwall Hospitals NHS Trust, Truro

CO4 5JL

Colchester Hospital University NHS Foundation Trust, Colchester

GL53 7AG

Glouchestershire Hospitals NHS Foundation Trust, Cheltenham

RG24 9NA

Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke

DN15 7BH

North Lincolnshire and Goole NHS Trust, Scunthorpe

NR31 6LA

James Paget University Hospital NHS Foundation Trust, Great Yarmouth

NR4 7UY

Norfolk and Norwich University Hospitals NHS Foundation Trust, Colney

0X3 9DU

Oxford Radcliffe Hospitals NHS Trust, Headington

BA21 4AT

Yeovil District Hospital NHS Foundation Trust, Yeovil

KT16 0PZ

Ashford & St Peters Hospitals NHS Foundation Trust, Chertsey

GU2 7XX

Royal Surrey County Hospital, Guildford

WF1 4EE

Mid Yorkshire Hospitals NHS Trust, Wakefield

SN3 6BB

Great Western Hospital, Swindon

PL6 8DH

Plymouth Hospitals NHS Trust, Plymouth